This finding is in line with a recent mouse study of Sierksma et al. (2020), where it was shown that the genetic risk of AD is functionally associated with the microglia response to amyloid-β pathology and not to phospho-tau pathology, suggesting that amyloid-β pathology is upstream of tau pathology [30]. Here, MAPT is linked to Alzheimer disease.